Sort   by:  
 Page size 
GenomicsDrug susceptible clinical isolates from individuals who failed treatment have increased potential to form viable but non-replicating populations of Mycobacterium tuberculosis
VBNR and TB treatment failure
PRJEB67335 | ENA
ProteomicsCulture filtrate of Mycobacterium tuberculosis clinical isolate S169
Phagosome acidification is one of the challenges faced by Mycobacterium tuberculosis during infection. This intracellular pathogen is known to adapt to its stressful environment though stress response pathways and by secreting proteins to modify the host immune response for survival and proliferatio...
ORGANISM(S): Mycobacterium tuberculosis 
2025-10-04 | PXD068720 | Pride
Acid stress Tuberculosis Heterogenous Persister Vbnr Tb 
Proteomicscell lysate of Mycobacterium tuberculosis clinical isolate S169
Phagosome acidification is one of the challenges faced by Mycobacterium tuberculosis during infection. This intracellular pathogen is known to adapt to its stressful environment though stress response pathways and by secreting proteins to modify the host immune response for survival and proliferatio...
ORGANISM(S): Mycobacterium tuberculosis 
2025-10-04 | PXD068623 | Pride
Acid stress Tuberculosis Heterogenous Persister Vbnr Tb 
UnknownAssessing the propensity of TB clinical isolates to form viable but non-replicating subpopulations.
Not available
S-EPMC11557868 | biostudies-literature
ProteomicsCulture filtrate of Mycobacterium tuberculosis clinical isolate S169 DIA
Phagosome acidification is one of the challenges faced by Mycobacterium tuberculosis during infection. This intracellular pathogen is known to adapt to its stressful environment through stress response pathways and by secreting proteins to modify the host immune response for survival and proliferati...
ORGANISM(S): Mycobacterium tuberculosis H37Rv 
2026-02-13 | PXD073840 | Pride
Tuberculosis Stress Dia 
Sort   by:  
 Page size